Abstract:Aberrant expression and phosphorylation of insulin receptor substrate 1 (IRS‐1) contribute to brain insulin resistance. However, the underlying mechanism remains elusive. The insulin signaling and Wnt/β‐catenin signaling are two critical pathways for normal cellular function, which interact in both peripheral tissues and the brain and may contribute to insulin resistance. In this study, we aimed to investigate the regulation of IRS‐1 and its downstream insulin signaling by Wnt/β‐catenin signaling in primary neurons. We found that the Wnt agonist Wnt3a enhances the insulin signaling in neurons at the basal state via up‐regulation of IRS‐1. Moreover, Wnt3a up‐regulates IRS‐1 expression and effectively ameliorates insulin resistance in rat primary neurons induced by chronic high insulin exposure. The insulin‐mediated glucose uptake is also stimulated by Wnt3a at both basal and insulin resistant states. We observed that Wnt activation up‐regulates IRS‐1 gene transcription and the subsequent protein expression in SH‐SY5Y cells and rat primary neurons via different means of Wnt/β‐catenin signaling activation, including S33Y β‐catenin over‐expression, CHIR99021 and Wnt3a treatment. We further clarified the molecular mechanism of IRS‐1 transcriptional activation by Wnt/β‐catenin signaling. The Wnt transcription factor TCF4 binds to the −529 bp to −516 bp of the human IRS‐1 promoter fragment and activates IRS‐1 transcription. Overall, these data suggested that Wnt/β‐catenin signaling positively regulates IRS‐1 and insulin signaling and protects against insulin resistance in neurons.

Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2.

The Insulin Receptor Adaptor IRS2 is an APC/C Substrate That Promotes Cell Cycle Protein Expression and a Robust Spindle Assembly Checkpoint

Regulation of Insulin Receptor Substrate‐1 Expression Levels by Caveolin‐1

Depletion of Insulin Receptor Substrate 2 Reverses Oncogenic Transformation Induced by V-Src

Activation of Wnt/β‐catenin Signaling Restores Insulin Sensitivity in Insulin Resistant Neurons Through Transcriptional Regulation of IRS‐1

Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells.

Phase Separation of Insulin Receptor Substrate 1 Drives the Formation of Insulin/igf-1 Signalosomes

Role of IRS-2 in insulin and cytokine signalling

Irs-2, but Not Irs-1, Can Sustain Proliferation and Rescue Ubf Stabilization in Inr or Inr Defective Signaling of 32d Myeloid Cells

WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2

Mtorc1-Regulated and HUWE1-Mediated WIPI2 Degradation Controls Autophagy Flux

Irtks Promotes Insulin Signaling Transduction Through Inhibiting Ship2 Phosphatase Activity

Wnt3a regulates proliferation, apoptosis and function of pancreatic NIT-1 beta cells via activation of IRS2/PI3K signaling.

Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and Β-Catenin

Insulin Receptor Substrate-1 Regulates The Transformed Phenotype Of Bt-20 Human Mammary Cancer Cells

Wnt Signaling Stabilizes The Dixdc1 Protein Through Decreased Ubiquitin-Dependent Degradation

The CUL7 E3 Ubiquitin Ligase Targets Insulin Receptor Substrate 1 for Ubiquitin-Dependent Degradation

Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death.

Oncogenic Function of DACT1 in Colon Cancer Through the Regulation of Β-Catenin.

Interaction Between Nuclear Insulin Receptor Substrate-2 and NF-κB in IGF-1 Induces Response in Breast Cancer Cells.

Overexpression of Insulin Receptor Substrate-1, But Not Insulin Receptor Substrate-2, Protects a T Cell Hybridoma from Activation-Induced Cell Death1